Javascript must be enabled to continue!
Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients
View through CrossRef
<div>Abstract<p><b>Purpose:</b> We previously reported a randomized phase II clinical trial combining a poxvirus-based vaccine encoding prostate-specific antigen (PSA) with radiotherapy in patients with localized prostate cancer. Here, we investigate whether vaccination against PSA induced immune responses to additional tumor-associated antigens and how this influenced clinical outcome.</p><p><b>Experimental Design:</b> Pretreatment and posttreatment serum samples from patients treated with vaccine + external beam radiation therapy (EBRT) versus EBRT alone were evaluated by Western blot and serologic screening of a prostate cancer cDNA expression library (SEREX) to assess the development of treatment-associated autoantibody responses.</p><p><b>Results:</b> Western blotting revealed treatment-associated autoantibody responses in 15 of 33 (45.5%) patients treated with vaccine + EBRT versus 1 of 8 (12.5%) treated with EBRT alone. SEREX screening identified 18 antigens, which were assembled on an antigen array with 16 previously identified antigens. Antigen array screening revealed that 7 of 33 patients (21.2%) treated with vaccine + EBRT showed a vaccine-associated autoantibody response to four ubiquitously expressed self-antigens: DIRC2, NDUFS1, MRFAP1, and MATN2. These responses were not seen in patients treated with EBRT alone, or other control groups. Patients with autoantibody responses to this panel of antigens had a trend toward decreased biochemical-free survival.</p><p><b>Conclusions:</b> Vaccine + EBRT induced antigen spreading in a large proportion of patients. A subset of patients developed autoantibodies to a panel of four self-antigens and showed a trend toward inferior outcomes. Thus, cancer vaccines directed against tumor-specific antigens can trigger autoantibody responses to self-proteins, which may influence the efficacy of vaccination. Clin Cancer Res; 16(15); 4046–56. ©2010 AACR.</p></div>
American Association for Cancer Research (AACR)
Title: Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients
Description:
<div>Abstract<p><b>Purpose:</b> We previously reported a randomized phase II clinical trial combining a poxvirus-based vaccine encoding prostate-specific antigen (PSA) with radiotherapy in patients with localized prostate cancer.
Here, we investigate whether vaccination against PSA induced immune responses to additional tumor-associated antigens and how this influenced clinical outcome.
</p><p><b>Experimental Design:</b> Pretreatment and posttreatment serum samples from patients treated with vaccine + external beam radiation therapy (EBRT) versus EBRT alone were evaluated by Western blot and serologic screening of a prostate cancer cDNA expression library (SEREX) to assess the development of treatment-associated autoantibody responses.
</p><p><b>Results:</b> Western blotting revealed treatment-associated autoantibody responses in 15 of 33 (45.
5%) patients treated with vaccine + EBRT versus 1 of 8 (12.
5%) treated with EBRT alone.
SEREX screening identified 18 antigens, which were assembled on an antigen array with 16 previously identified antigens.
Antigen array screening revealed that 7 of 33 patients (21.
2%) treated with vaccine + EBRT showed a vaccine-associated autoantibody response to four ubiquitously expressed self-antigens: DIRC2, NDUFS1, MRFAP1, and MATN2.
These responses were not seen in patients treated with EBRT alone, or other control groups.
Patients with autoantibody responses to this panel of antigens had a trend toward decreased biochemical-free survival.
</p><p><b>Conclusions:</b> Vaccine + EBRT induced antigen spreading in a large proportion of patients.
A subset of patients developed autoantibodies to a panel of four self-antigens and showed a trend toward inferior outcomes.
Thus, cancer vaccines directed against tumor-specific antigens can trigger autoantibody responses to self-proteins, which may influence the efficacy of vaccination.
Clin Cancer Res; 16(15); 4046–56.
©2010 AACR.
</p></div>.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients
Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients
<div>Abstract<p><b>Purpose:</b> We previously reported a randomized phase II clinical trial combining a poxvirus-based vaccine encoding prostate-specific an...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Correlation between Prostate-Specific Antigen Levels and Prostate Imaging Reporting and Data System score: A Retrospective Study
Correlation between Prostate-Specific Antigen Levels and Prostate Imaging Reporting and Data System score: A Retrospective Study
Introduction: Prostate cancer is a prevalent and potentially lethal malignancy affecting men worldwide. To enhance early detection and accurate risk stratification, various diagnos...
Analysis of the spatial distribution and clinical features of prostate cancer in transperineal prostate biopsy
Analysis of the spatial distribution and clinical features of prostate cancer in transperineal prostate biopsy
Abstract
Background Recently, most studies on the spatial distribution of the prostate cancer are based on the samples confirmed by transrectal prostate biopsy (TRBx), whic...
The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer
The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer
Introduction: To increase the detection rate of prostate cancer inrecent years, we examined the increase in the number of corestaken at initial prostate biopsy. We hypothesized tha...
Preliminary study on miRNA in prostate cancer
Preliminary study on miRNA in prostate cancer
Abstract
Objective
To screen for miRNAs differentially expressed in prostate cancer and prostate hyperplasia tissues and to validate their association with prostate cancer...
Abstract 1341: Identification of significant linkage evidence for lethal prostate cancer on chromosome arm 11p15.
Abstract 1341: Identification of significant linkage evidence for lethal prostate cancer on chromosome arm 11p15.
Abstract
We performed genome wide linkage analysis in a set of high-risk prostate cancer pedigrees, each with 3 or more sampled cases whose death certificate indicat...

